This deal adds two more siRNA candidates to GSK’s pipeline, which is expanding as the company looks to offset the impact of ...
When considering factors like disease biology and patient needs in drug discovery and development, the goal is to deliver effective and scalable treatments globally by balancing established approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results